CME Insider Patrick Maloney Buys $145K of Stock
Insider Patrick Maloney acquired 645 shares of CME Group for $145,125, as the stock hovers near its 52-week low.
Reviewed by automated data checks against the source filing. How we make and check alerts
Patrick Maloney bought 645 shares of CME Group Inc. ($CME) at an average price of $225, worth about $145,125, on June 25, 2026. The trade was reported to the SEC in a Form 4 filing.
Since the trade, $CME is up 5.2% after 1 week, up 13.5% after 1 month and up 31.2% to date (from the $223.95 close on Jun 25, 2026).
CME
CME Group Inc.
Key Points
- On June 25, 2026, Patrick Maloney bought 645 shares of CME Group Inc. for $145,125 at $225 each, as the stock trades at $218.58.
- CME Group's stock is currently near its 52-week low of $218.31, following a previous close of $276.01.
- Analysts have a consensus hold rating on CME Group, with a mean price target of $283.6 from 15 opinions.
Get $CME trade alerts by text
We text you when insiders, Congress or big funds trade $CME. Free.
Not investment advice. EarningsIQ is not a registered investment adviser, and this automated CME Group Inc. alert may contain errors. Disclosures
Insider Buying and Selling at CME Group Inc.
On June 25, 2026, Patrick Maloney bought 645 shares of CME Group Inc. (CME) for $145,125. The shares were purchased at an average price of $225 each. This move comes as the stock trades at $218.58, indicating a significant drop from its previous close of $276.01.
Other Insiders Active on the Same Day
Maloney wasn't the only insider making moves on June 25. Several others also bought shares of CME Group. Timothy Bitsberger, Daniel Kaye, Tierney Robert Jr., and Bryan Durkin each purchased 645 shares for $145,125 at the same price of $225. Ford Harold Eugene Jr. took a larger position, buying 1,067 shares valued at $240,075. All these transactions highlight a collective confidence among insiders in the company's future.
How CME Group Inc. Stock Has Traded
CME Group's stock is currently trading near its 52-week low of $218.31, which might be a concern for some investors, especially considering its previous high of $329.16. The stock's decline has been noticeable, and this insider buying could suggest a belief in a future rebound. With a market cap of approximately $99.1 billion and a P/E ratio of 23.37, the stock is under pressure but still holds potential according to some analysts.
Analysts Set New Price Targets
Analysts have maintained a generally positive outlook on CME Group. On October 14, 2026, Wells Fargo maintained its Overweight rating, raising the price target to $315 from $301. Morgan Stanley also holds an Overweight rating with a target of $337, while Barclays rates the stock as Equal-Weight with a target of $281. The overall consensus is a hold, with a mean price target of $283.6 based on 15 analyst opinions.
What CME Group Inc. Does
CME Group Inc. operates as a global marketplace for trading futures and options on futures contracts. It offers a variety of products across different sectors, including interest rates, equity indexes, and commodities. The company's operations are crucial for various market participants, including financial institutions and individual investors, which is why insider buying activity is particularly noteworthy.
What's Ahead for CME Group Inc.
CME Group is set to report its next earnings on October 21, 2026. Investors will be looking for insights into its performance and any potential recovery in the stock price. The recent insider purchases reflect a confidence in the company’s long-term prospects, but the 13F filings remind us that these positions may not represent current holdings. Monitoring further insider activity and analyst updates will be essential in the coming months.
Related Filing Alerts
Source: Patrick Maloney's Form 4 filing on $CME (Jun 25, 2026). Find the original filing: CME Form 4 filings on SEC EDGAR. Written by software, not financial advice. How we make alerts